|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Dr. Spodick is Professor of Medicine, University of Massachusetts Medical School; and is also affiliated with the Cardiovascular Division, Saint Vincent Hospital.
Correspondence to: David H. Spodick, MD, DSc, FCCP, Saint Vincent Hospital, 25 Winthrop St, Worcester, MA 01604
Bleeding in any tissue is always concerning and potentially serious, either as a marker of disease or of potential blood loss. Hemopericardium (Table 1 ) comprises sanguineous pericardial effusions (which do not clot), frank blood due to wounds, and rupture into the pericardium of cardiovascular structures. The latter usually overwhelms the fibrinolytic and anticlotting activities of the pericardial mesothelium1 and therefore usually clots. In cases of frank bleeding, the cause is frequently manifest or rapidly becomes so. Bloody pericardial effusion, on the other hand, is diagnostically more challenging because of the wide variety of conditions that simultaneously produce fluid (mostly exudates) and various degrees of bleeding into it, presumably from irritated capillaries. Contemporary experience indicates the very broad range of effusions, including common viral pericarditides, that may exhibit sanguineous pericardial effusion,2 in contrast to the time-dishonored teachings about the frequency of life-threatening underlying lesions, notably tuberculosis. With the exception of AIDS patients, tuberculosis has been disappearing, at least in the industrialized Western world. Of course, diagnostic specificity is heavily related to the prevalence of any disorder in a given population, and the skewed populations of referral centers and institutions, which have developed populations of particular kinds of patients, will reflect this.
|
Atar and colleagues present a picture of symptoms, signs (including pulsus paradoxus), ECG abnormalities, and imaging abnormalities that reflect contemporary experience, as do their mortality statistics: patients with malignancy-related effusions died within months, excepting those with lymphomata, while patients with iatrogenic and idiopathic bloody effusions survived quite nicely. Moreover, the authors point out the overall poor results of effusion cytology studies and cultures (laboratory results changed the prepericardiocentesis diagnosis in only 3 of 96 patients). Indeed, only 12 patients had any positive findings in their pericardial fluid. Pericardial biopsy was performed at the discretion of the patients physician and is not reported. This is probably because there were either too few biopsies or those that were obtained were not helpful. This would reflect a common experience that the results of pericardial biopsies are either negative or nonspecific, probably because both normal and abnormal pericardial fluids exude via the visceral pericardium, containing combinations of substances from the cardiac interstitium and the visceral pericardial mesothelium. Yet, a biopsy of the visceral pericardium is almost never performed. A potentially productive investigation would be to perform a biopsy of the visceral pericardium at surgery or by pericardioscopy (taking care to avoid the coronary vessels) in patients for whom determining etiology could provide targets for specific therapy.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |